Lisa Diller

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 study
    Janet S de Moor
    Division of Health Behavior and Health Promotion, The Ohio State University College of Public Health, Columbus, OH, USA
    BMC Cancer 11:165. 2011
  2. ncbi request reprint Constitutional WT1 mutations in Wilms' tumor patients
    L Diller
    Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 16:3634-40. 1998
  3. ncbi request reprint Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study
    Lisa Diller
    Department of Medicine, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 20:2085-91. 2002
  4. pmc Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks
    Jennifer M Yeh
    Center for Health Decision Science, Harvard School of Public Health, Boston, MA, USA
    Blood 120:2195-202. 2012
  5. doi request reprint Health status of the oldest adult survivors of cancer during childhood
    Lisa B Kenney
    Department of Hematology Oncology, Children s Hospital, Boston, Massachusetts, USA
    Cancer 116:497-505. 2010
  6. ncbi request reprint High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update
    Rani E George
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 24:2891-6. 2006
  7. ncbi request reprint Perceptions of breast cancer risk and cancer screening: a qualitative study of young, female Hodgkin's disease survivors
    Sharon L Bober
    Dana Farber Cancer Institute, Boston, MA02115, USA Sharon_bober dfci harvard edu
    J Cancer Educ 22:42-6. 2007
  8. pmc Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study
    Wendy B London
    Division of Hematology Oncology, Children s Hospital Boston Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA
    J Clin Oncol 28:3808-15. 2010
  9. doi request reprint Tumor histology during induction therapy in patients with high-risk neuroblastoma
    Rani E George
    Department of Pediatric Hematology and Oncology, Dana Farber Cancer Institute and Children s Hospital, Boston, MA 02115, USA
    Pediatr Blood Cancer 59:506-10. 2012
  10. pmc Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays
    Rani E George
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America
    PLoS ONE 2:e255. 2007

Detail Information

Publications43

  1. pmc Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 study
    Janet S de Moor
    Division of Health Behavior and Health Promotion, The Ohio State University College of Public Health, Columbus, OH, USA
    BMC Cancer 11:165. 2011
    ..Partnership for Health-2 (PFH-2) is a web-based version of Partnership for Health, an evidence-based smoking cessation intervention for childhood cancer survivors. This paper describes the PFH-2 intervention and baseline data collection...
  2. ncbi request reprint Constitutional WT1 mutations in Wilms' tumor patients
    L Diller
    Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 16:3634-40. 1998
    ..We sought to determine the frequency of constitutional WT1 mutations in a larger cohort, and to identify clinical manifestations associated with the risk for carrying a WT1 mutation...
  3. ncbi request reprint Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study
    Lisa Diller
    Department of Medicine, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 20:2085-91. 2002
    ....
  4. pmc Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks
    Jennifer M Yeh
    Center for Health Decision Science, Harvard School of Public Health, Boston, MA, USA
    Blood 120:2195-202. 2012
    ..Initial treatment with CT may be associated with longer average per-person life expectancy. These results support the need for careful consideration of the risk-benefit profile of radiation as frontline therapy in pediatric patients...
  5. doi request reprint Health status of the oldest adult survivors of cancer during childhood
    Lisa B Kenney
    Department of Hematology Oncology, Children s Hospital, Boston, Massachusetts, USA
    Cancer 116:497-505. 2010
    ..Young adult survivors of childhood cancer have an increased risk for treatment-related morbidity and mortality. In this study, the authors assessed how treatment for childhood cancer affects older-adult health and health practices...
  6. ncbi request reprint High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update
    Rani E George
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 24:2891-6. 2006
    ..To provide an update on long-term survival of patients with high-risk neuroblastoma treated with tandem cycles of myeloablative therapy and peripheral-blood stem-cell rescue (PBSCR)...
  7. ncbi request reprint Perceptions of breast cancer risk and cancer screening: a qualitative study of young, female Hodgkin's disease survivors
    Sharon L Bober
    Dana Farber Cancer Institute, Boston, MA02115, USA Sharon_bober dfci harvard edu
    J Cancer Educ 22:42-6. 2007
    ..Young female Hodgkins Disease (HD) survivors are at high risk for breast cancer following chest irradiation. We explored health perceptions, screening behaviors, and barriers of this population...
  8. pmc Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study
    Wendy B London
    Division of Hematology Oncology, Children s Hospital Boston Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA
    J Clin Oncol 28:3808-15. 2010
    ..Because responders often underwent further therapies, novel statistical methods were required to compare the long-term outcome of the two treatments...
  9. doi request reprint Tumor histology during induction therapy in patients with high-risk neuroblastoma
    Rani E George
    Department of Pediatric Hematology and Oncology, Dana Farber Cancer Institute and Children s Hospital, Boston, MA 02115, USA
    Pediatr Blood Cancer 59:506-10. 2012
    ..We sought to determine whether histological changes in the primary tumor following induction therapy could be used as a marker of response...
  10. pmc Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays
    Rani E George
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America
    PLoS ONE 2:e255. 2007
    ..We analyzed paired blood and primary tumor samples from 22 children with high-risk neuroblastoma for loss of heterozygosity (LOH) and DNA copy number change using the Affymetrix 10K single nucleotide polymorphism (SNP) array...
  11. pmc General internist communication about sexual function with cancer survivors
    Elyse R Park
    Institute for Health Policy, Massachusetts General Hospital, Harvard Medical School, 50 Staniford Street, Boston, MA 02114, USA
    J Gen Intern Med 24:S407-11. 2009
    ..Sexual dysfunction is an important issue that affects many cancer survivors who are increasingly being cared for by internists...
  12. doi request reprint Caring for cancer survivors: a survey of primary care physicians
    Sharon L Bober
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, and Institute for Health Policy, Massachusetts General Hospital, Boston, Massachusetts 02115, USA
    Cancer 115:4409-18. 2009
    ....
  13. ncbi request reprint Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study
    Rani E George
    Department of Pediatric Hematology and Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 23:6466-73. 2005
    ..To determine predictive strength of tumor cell ploidy and MYCN gene amplification on survival of children older than 12 months with disseminated neuroblastoma (NB)...
  14. doi request reprint Decision analysis to compare treatment strategies for Stage I/favorable histology Wilms tumor
    A Lindsay Frazier
    Department of Pediatric Oncology, Dana Farber Children s Hospital Cancer Care, Harvard Medical School, Boston, Massachusetts 02115, USA
    Pediatr Blood Cancer 54:879-84. 2010
    ..Decision analysis was used to clarify differences in survival and complication rates comparing surgery alone versus surgery plus chemotherapy for Stage I, favorable histology Wilms tumor patients...
  15. doi request reprint The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the Consortium for New England Childhood Cancer Survivors
    Lisa B Kenney
    Dana Farber Cancer Institute and Children s Hospital, Boston, Massachusetts 02115, USA
    Pediatr Blood Cancer 57:1062-6. 2011
    ..It has not been determined if pediatric oncology programs have successfully incorporated these standards for long term survivor care into clinical practice...
  16. doi request reprint Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy
    Laura McCullough
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Cancer 116:4866-71. 2010
    ..In the current study, the rates of successful breastfeeding in long-term survivors who received chest radiotherapy (CXRT) as a treatment for Hodgkin lymphoma (HL) were examined...
  17. ncbi request reprint Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study
    Lisa B Kenney
    Children s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
    Ann Intern Med 141:590-7. 2004
    ..Survivors of childhood cancer are at risk for secondary breast cancer. Other than previous chest radiation therapy, risk factors for secondary breast cancer have not been established...
  18. doi request reprint Ovarian tissue autologous transplantation to the upper extremity for girls receiving abdominal/pelvic radiation: 20-year follow-up of reproductive endocrine function
    Marc R Laufer
    Division of Gynecology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Pediatr Adolesc Gynecol 23:107-10. 2010
    ..Upper-extremity ovarian autologous transplantation was first used for girls undergoing abdominal/pelvic radiation therapy; long-term follow-up is provided...
  19. ncbi request reprint The effects of response bias on self-reported quality of life among childhood cancer survivors
    Lisa Diller
    Suffolk University, Boston, MA, USA
    Qual Life Res 16:1211-20. 2007
    ..This study tested the hypothesis that CCS are elevated on self-deception response bias (SDRB), and that SDRB is associated with higher ratings of quality-of-life (QOL)...
  20. ncbi request reprint Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study
    Karen Emmons
    Division of Community Based Research, Dana Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02067, USA
    J Clin Oncol 20:1608-16. 2002
    ..To examine the determinants of smoking behavior among participants in the Childhood Cancer Survivors Study (CCSS)...
  21. ncbi request reprint Utility of routine psychological screening in the childhood cancer survivor clinic
    Christopher Recklitis
    David B Perini Jr Quality of Life Clinic, The Dana Farber Cancer Institute, Boston, MA, USA
    J Clin Oncol 21:787-92. 2003
    ....
  22. pmc Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study
    Rani E George
    Department of Pediatric Oncology, Dana Farber Cancer Institute and Children s Hospital, Boston, Massachusetts 02115, USA rani
    Pediatr Blood Cancer 55:629-38. 2010
    ..We conducted a phase I trial to determine the toxicity and molecular effects of the demethylating agent, decitabine, followed by doxorubicin and cyclophosphamide in children with refractory solid tumors...
  23. pmc A model-based estimate of cumulative excess mortality in survivors of childhood cancer
    Jennifer M Yeh
    Harvard School of Public Health, Harvard Medical School Harvard Pilgrim Health Care Institute and Harvard Vanguard Medical Associates, Dana Farber Cancer Institute and Children s Hospital, Boston, Massachusetts, and Emory University, Atlanta, Georgia, USA
    Ann Intern Med 152:409-17, W131-8. 2010
    ..Although childhood cancer survival rates have dramatically increased, survivors face elevated risk for life-threatening late effects, including secondary cancer...
  24. ncbi request reprint Perioperative management of a child with severe hypertension from a catecholamine secreting neuroblastoma
    Christian Seefelder
    Department of Anesthesiology, Perioperative and Pain Medicine, Children s Hospital, Boston, MA 02115, USA
    Paediatr Anaesth 15:606-10. 2005
    ..After blood pressure control using phenoxybenzamine and enalapril, doxazosin was used successfully as the preoperative alpha-adrenergic receptor antagonist for surgical tumor resection...
  25. doi request reprint Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers
    Ming Hui Chen
    Department of Cardiology, Children s Hospital Boston, 300 Longwood Ave, Boston, MA 02115, USA
    Circ Res 108:619-28. 2011
    ..Basic and translational research is urgently needed to clarify pathophysiologic mechanisms of late cardiac effects and to develop therapies to improve both long-term survival and quality of life of adults cured of pediatric cancers...
  26. doi request reprint Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort
    Sara E Barton
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA Electronic address
    Lancet Oncol 14:873-81. 2013
    ..We investigated infertility and time to pregnancy in female childhood cancer survivors, and analysed treatment characteristics associated with infertility and subsequent pregnancy...
  27. doi request reprint Pharmacotherapy of neuroblastoma
    Rani E George
    Dana Faber Cancer Institute, Department of Pediatric Oncology, Boston, MA, USA
    Expert Opin Pharmacother 11:1467-78. 2010
    ..High risk disease in older children remains a therapeutic challenge, despite high-intensity therapy with correspondingly significant short- and long-term toxicities...
  28. pmc Activating mutations in ALK provide a therapeutic target in neuroblastoma
    Rani E George
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
    Nature 455:975-8. 2008
    ....
  29. pmc Long-term smoking cessation outcomes among childhood cancer survivors in the Partnership for Health Study
    Karen M Emmons
    Harvard School of Public Health and Dana Farber Cancer Institute, Center for Community Based Research, Boston, MA 02115, USA
    J Clin Oncol 27:52-60. 2009
    ....
  30. ncbi request reprint Transitioning to survivorship: a pilot study
    Eileen C Duffey-Lind
    Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    J Pediatr Oncol Nurs 23:335-43. 2006
    ..Further research is needed to look at the unmet educational and psychological needs of childhood cancer survivors and their parents during the critical time when they transition off treatment...
  31. ncbi request reprint Association between congenital cardiovascular malformations and neuroblastoma
    Rani E George
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
    J Pediatr 144:444-8. 2004
    ..We explored the association between neuroblastoma and congenital cardiovascular malformations (CCM), previously described in case reports...
  32. ncbi request reprint Screening adult survivors of childhood cancer with the distress thermometer: a comparison with the SCL-90-R
    Christopher J Recklitis
    Perini Family Survivors Center, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Psychooncology 16:1046-9. 2007
    ..1%). Receiver operating characteristics analysis indicated that the DT had only fair diagnostic utility relative to the SCL-90-R (AUC=0.72). Results do not support the validity of the DT in adult survivors of childhood cancer...
  33. ncbi request reprint CT-guided radiofrequency ablation of pediatric Wilms tumor in a solitary kidney
    Stephen D Brown
    Department of Radiology, Children s Hospital, 300 Longwood Ave, Boston, MA 02115, USA
    Pediatr Radiol 35:923-8. 2005
    ..Various specific technical issues differentiate pediatric from adult tumor ablation, including the amount of intra-abdominal fat, need for smaller grounding pads, and potential systemic effects of tissue heating...
  34. ncbi request reprint Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants
    Karen J Marcus
    Division of Radiation Oncology, Children s Hospital, Harvard Medical School, Boston, Massachusetts 02155, USA
    J Pediatr Hematol Oncol 25:934-40. 2003
    ..To assess the efficacy and toxicity of local radiotherapy in achieving local control in patients with stage 4 or high-risk stage 3 neuroblastoma treated with induction chemotherapy and tandem stem cell transplants...
  35. ncbi request reprint TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms
    Kim E Nichols
    Department of Pediatric Oncology, Children s Hospital of Philadelphia, PA, USA
    J Clin Oncol 21:4505-9. 2003
    ..To clarify whether host genetic factors contribute to secondary tumorigenesis, we performed mutational analyses of the TP53, BRCA1, and BRCA2 tumor suppressor genes in a cohort of 44 HD patients developing one or more SMN...
  36. ncbi request reprint Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy
    M Jacob Adams
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, NY, USA
    J Clin Oncol 22:3139-48. 2004
    ..Cardiovascular status was assessed in 48 Hodgkin's disease (HD) survivors at a median of 14.3 years (range, 5.9 to 27.5 years) after diagnosis because they may be at increased risk for cardiovascular abnormalities...
  37. ncbi request reprint Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant
    Daniel von Allmen
    Division of Pediatric Surgery, Department of Surgery, University of North Carolina, Chapel Hill, NC 27599, USA
    J Pediatr Surg 40:936-41; discussion 941. 2005
    ..Local tumor control is examined in high-risk patients treated with tandem stem cell transplant, aggressive surgery, and selected radiation therapy (XRT)...
  38. ncbi request reprint High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group
    Smita Bhatia
    City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010 3000, USA
    J Clin Oncol 21:4386-94. 2003
    ..We describe the pattern and incidence of subsequent neoplasms (SNs) occurring with extended follow-up...
  39. ncbi request reprint Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis
    Vlad C Radulescu
    East Tennessee State University, Johnson City, Tennessee, USA
    Pediatr Blood Cancer 50:246-9. 2008
    ..This study was undertaken to describe the treatment and outcomes of patients with recurrent CCSK involving the brain...
  40. ncbi request reprint Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study
    Tara O Henderson
    Department of Pediatrics, Section of Hematology Oncology, Pritzker School of Medicine, University of Chicago, 5841 South Maryland Ave, MC 4060, Chicago, IL 60637, USA
    J Natl Cancer Inst 99:300-8. 2007
    ..We analyzed a large cohort of childhood cancer survivors to determine the true incidence of secondary sarcomas and to examine factors associated with the risk of developing secondary sarcomas...
  41. doi request reprint Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study
    Daniel A Mulrooney
    Department of Pediatrics, University of Minnesota Medical School and Cancer Center, Minneapolis, MN 55455, USA
    Cancer 112:2071-9. 2008
    ..Limited data exist on the comprehensive assessment of late medical and social effects experienced by survivors of childhood and young adult acute myeloid leukemia (AML)...
  42. pmc Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project
    Steven G DuBois
    Department of Pediatrics, University of California, San Francisco, California, USA
    Pediatr Blood Cancer 51:589-92. 2008
    ..We aimed to describe the incidence, clinical characteristics, and outcome of patients with lung metastasis at initial diagnosis using a large international database...
  43. ncbi request reprint Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study
    Lisa A Moreau
    The National Center for Pediatric Cancer Genetics, Children s Oncology Group, University of Florida, Gainesville, FL, USA
    Clin Cancer Res 12:5693-7. 2006
    ..The aim of this study was to determine whether children with neuroblastoma in which MYCN oncogene amplification is manifested as HSRs at diagnosis have a worse prognosis than those whose tumors exhibit dmins...